SAXENDA 6 mg/ml, solution for injection in a pre-filled pen cartridge, 3 ml
Brand page: Saxenda (liraglutide) — all forms and strengths in France
Active ingredients: Liraglutide
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injectioncartridge, 3 mlsous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- SAXENDA 6 mg/ml, solution injectable en stylo prérempli
- Pharmaceutical form
- solution injectable
- Route of administration
- sous-cutanée
- Presentation description
- cartouche(s) en verre multidose(s) de 3 ml dans 3 stylos préremplis jetables
- Marketing authorisation holder
- NOVO NORDISK (DANEMARK)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 2 Mar 2021
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61756418CIP73021057CIP133400930210574Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LIRAGLUTIDEsolution | 6 mg · 1 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.